Abstract

ObjectivesWe aimed to assess the safety experience of women vaccinated with vaccines against SARS-CoV-2 during breastfeeding or pregnancy. MethodsVia an online questionnaire, we have inquired about the safety experience of 2192 pregnant or breastfeeding women vaccinated against SARS-CoV-2, including the incidence of adverse events (AEs), pregnancy outcomes, and confirmed infection with SARS-CoV-2. ResultsThe incidence of other AEs was higher in women vaccinated during breastfeeding. Significant differences were observed for fatigue (relative risk [RR] 1.230, 95% confidence interval [CI] 1.051-1.444, P = 0.0098), headache (RR 1.822, 95% CI 1.379-2.418, P <0.0001), myalgia (RR 1.633, 95% CI 1.269-2.110, P <0.0001), chills (RR 2.027, 95% CI, P <0.0001), subfebrile temperature ≤38°C (RR 1.697, 95% CI 1.240-2.335, P = 0.0007), arthralgia (RR 1.924, 95% CI 1.340-2.776, P = 0.0002), fever >38°C (RR 6.410, 95% CI 2.890-14.30, P <0.0001), and shivers (RR 2.204, 95% CI 1.264-3.863, P = 0.0049). No pattern of serious AEs emerged. Menstrual cycle bleeding disorders occurred in 0.7% of breastfeeding women after the first dose and 0.5% after the second dose. One spontaneous abortion occurred; 93.1% of pregnancies were carried to term, 5.6% late preterm, 0.9% moderate preterm, and 0.3% very preterm. Two children had congenital defects. Vaccine efficacy was 96.3%. ConclusionThe safety profile of SARS-CoV-2 vaccines in pregnant and breastfeeding women was similar to the general population. Breastfeeding women experienced higher AE rates than pregnant women, presumably due to immune alterations in pregnancy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.